Skip to main content

UBS Group AG

Position in PMCB — PharmaCyte Biotech, Inc.

CIK 1610520 ZURICH, V8

Position in PMCB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,189
+$184 QoQ
Shares Held
4,142
-8.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 30 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PMCB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. PMCB ranks #484 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PMCB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,189 4,142
2026-03-31 $3,005 4,519
2025-12-31 $1,987 2,746
2025-09-30 $1,281 1,323
2025-06-30 $24,624 22,592
2025-03-31 $14,894 11,916
2024-12-31 $2,940 1,874
2024-09-30 $15,954 8,354
2024-06-30 $54,045 27,575
2024-03-31 $20 9
2023-12-31 $26 13
2023-09-30 $18 9
2023-06-30 $25 9
2023-03-31 $4,910 1,688
2022-12-31 $25 9
2022-09-30 $21 9
2022-06-30 $19 9
2022-03-31 $13,412 5,832
2021-12-31 $9,152 3,661
2021-09-30 $10,780 3,401